These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6129728)

  • 1. May enzyme activity in urine play a role in kidney stone formation?
    Azoury R; Garti N; Perlberg S; Sarig S
    Urol Res; 1982; 10(4):185-9. PubMed ID: 6129728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retardation of calcium oxalate precipitation by glutamic-oxalacetic-transaminase activity.
    Azoury R; Sarig S; Garti N; Perlberg S
    Urol Res; 1982; 10(4):169-72. PubMed ID: 7179608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observations on calcium oxalate stone formers.
    el-Sharabasy MM
    Br J Urol; 1992 Nov; 70(5):474-7. PubMed ID: 1361403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological control to diminish dangers of urolithiasis.
    Sarig S; Azoury R; Garti N
    Urol Int; 1985; 40(5):274-6. PubMed ID: 2866620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of GOT activity on nucleation and crystal growth of calcium oxalate.
    Azoury R; Sarig S; Garti N; Perlberg S; Randolph AD; Drach GW
    Urol Res; 1984; 12(4):223-6. PubMed ID: 6149642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of glutamic acid and aspartic acid on calcium oxalate crystal formation.
    Kohri K; Umekawa T; Kodama M; Katayama Y; Ishikawa Y; Takada M; Katoh Y; Kataoka K; Iguchi M; Kurita T
    Eur Urol; 1990; 17(2):173-7. PubMed ID: 1968835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL; Hibberd CM; Mazzachi BC; Marshall VR
    Clin Chim Acta; 1986 Jan; 154(1):59-67. PubMed ID: 3943225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A method for discrimination between calcium oxalate kidney stone formers and normals.
    Sarig S; Garti N; Azoury R; Wax Y; Perlberg S
    J Urol; 1982 Sep; 128(3):645-9. PubMed ID: 6214645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in inhibitory potential in urine of hyperuricosuric calcium oxalate stone formers effected by allopurinol and orthophosphates.
    Goldwasser B; Sarig S; Azoury R; Wax Y; Hirsch D; Perlberg S; Many M
    J Urol; 1984 Nov; 132(5):1008-11. PubMed ID: 6492268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium oxalate nephrolithiasis: an easy way to detect an imbalance between promoting and inhibiting factors.
    Baggio B; Gambaro G; Oliva O; Favaro S; Borsatti A
    Clin Chim Acta; 1982 Sep; 124(2):149-55. PubMed ID: 6216029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amino acid factor in stone formers' and normal urines.
    Azoury R; Garti N; Sarig S
    Urol Res; 1986; 14(6):295-8. PubMed ID: 3544447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of GAGS on 24-hour and 2-hour urines from calcium oxalate stone formers and healthy subjects.
    Gianotti M; Genestar C; Palou A; Pons A; Conte A; Grases F
    Int Urol Nephrol; 1989; 21(3):281-8. PubMed ID: 2807779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
    Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
    Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial crystalluria determination and the risk of recurrence in calcium stone formers.
    Daudon M; Hennequin C; Boujelben G; Lacour B; Jungers P
    Kidney Int; 2005 May; 67(5):1934-43. PubMed ID: 15840041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers.
    Massey LK; Sutton RA
    J Urol; 2004 Aug; 172(2):555-8. PubMed ID: 15247728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.